Angela Shen

1 month ago | chinatalk.media | Angela Shen

This continues a series examining China’s role in the global biotech and pharmaceutical industry, and focuses on China’s drug markets. Our first piece explored the role of AI in China’s biotech ecosystem. Future articles will cover the Chinese biopharmaceutical research, innovation, and supply chains. If you have tips on any of these topics, please reach out. As China prospers, so do its citizens’ expectations for high-quality healthcare.

1 month ago | chinatalk.media | Angela Shen

Founded in 2023, Moonshot AI is one of China’s four new “AI tigers” that’s attracted massive valuations and big-name investors including Alibaba and Tencent. The firm is known for its chatbot, Kimi, whose most recent release highlights improved math, coding, and multimodal reasoning capabilities. The following piece is a translation of an interview with one of Moonshot’s founders, Yang Zhiling.

1 month ago | chinatalk.media | Angela Shen

Today we’re doing an anonymous Q&A with KL Divergence, a robotics PhD currently in industry working on humanoid robots. For an introduction to humanoid robotics in China, see our article here, and for a deeper look into who’s leading China’s humanoid market, see our latest translated interview with the CEO of Unitree Robotics.

1 month ago | chinatalk.media | Angela Shen

Hangzhou-based Unitree Robotics is among the top players in China’s robotics industry, developing best-selling civilian quadruped and humanoid robots. Unitree’s H1 humanoids captivated over a billion people with a traditional folk dance performance during China’s 2025 Spring Festival Gala. Just weeks later, Unitree’s CEO was the youngest front-row participant in Beijing’s highly-anticipated private sector summit.